| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cannabinoid receptor 2 |
|---|
| Ligand | BDBM50516300 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1864130 (CHEMBL4365105) |
|---|
| Ki | 170±n/a nM |
|---|
| Citation |  Montanari, S; Mahmoud, AM; Pruccoli, L; Rabbito, A; Naldi, M; Petralla, S; Moraleda, I; Bartolini, M; Monti, B; Iriepa, I; Belluti, F; Gobbi, S; Di Marzo, V; Bisi, A; Tarozzi, A; Ligresti, A; Rampa, A Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment. Eur J Med Chem178:243-258 (2019) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cannabinoid receptor 2 |
|---|
| Name: | Cannabinoid receptor 2 |
|---|
| Synonyms: | CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2 |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 39690.94 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P34972 |
|---|
| Residue: | 360 |
|---|
| Sequence: | MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILS
SHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTAS
VGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCS
ELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLD
VRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYA
LRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
|
|
|
|---|
| BDBM50516300 |
|---|
| n/a |
|---|
| Name | BDBM50516300 |
|---|
| Synonyms: | CHEMBL4464357 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C29H23NO3 |
|---|
| Mol. Mass. | 433.4978 |
|---|
| SMILES | COc1ccc(cc1)-c1oc2ccccc2c1C(=O)c1ccc(NCc2ccccc2)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
